45th week of 2010 patent applcation highlights part 36 |
Patent application number | Title | Published |
20100285095 | Hygiene Article Having Calcium Sugar Acid Salt - A hygiene article having calcium sugar acid salt is provided. The calcium sugar acid salt reduces the production of Toxic Shock Syndrome Toxin-1 (TSST-1) by | 2010-11-11 |
20100285096 | Hygiene Article Having Calcium Sugar Phosphate - A hygiene article having calcium sugar phosphate is provided. The calcium sugar phosphate reduces the production of Toxic Shock Syndrome Toxin-1 (TSST-1) by | 2010-11-11 |
20100285097 | VAGINAL DELIVERY SYSTEM - The present invention is related to an intravaginal delivery system for the controlled release of drospirenone and an estrogen, optionally also comprising one or more therapeutically active or a health-promoting substance capable of giving and/or enhancing protection against bacterial and fungal infections, and/or enhancing protection against sexually transmitted diseases. The delivery system consists of one or more compartments, one of each comprising a core and a membrane encasing the core, said core and membrane essentially consisting of a same or different polymer composition, wherein at least one compartment comprises drospirenone ant at least one compartment which may be the same or different from the one comprising drospirenone, comprises an estrogen or a mixture of drospirenone and an estrogen, and wherein the membrane or the surface of the membrane or at least one of the cores comprises said therapeutically active or a health-promoting substance. | 2010-11-11 |
20100285098 | ADHERING TROCHES WITH SANTACID FOR TREATMENT OF THROAT ESOPHAGUS AND STOMACH - A method for combating unwanted conditions downstream of the mouth with adhering troches. A method to treat or reduce replication of a virus in throat tissues by releasing an anti-viral from an adhering disc. A method to treat sore throat with time release of Glycyrrhiza extract or collagen from an adhering disc. A method to treat sore throat with topically applied cobalamin. An adhering troche that releases antacid, alginate, bismuth subsalicylate, soluble zinc, such as zinc gluconate, bioactive vitamin B12 (methylcobalamin), antibiotic, or anti-viral. A method to combat bacterial effects downstream of the mouth with topically applied xylitol. | 2010-11-11 |
20100285099 | VACCINATION BY TRANSCUTANEOUS TARGETING - The present invention relates to a method of vaccination via hair follicles that makes it possible to target vaccine components to the antigen-presenting cells in order to induce a protective and effective immune response against pathogens. | 2010-11-11 |
20100285100 | COMPOSITIONS AND MEDICAL DEVICES FOR CONTROLLED RELEASE OF NITRIC OXIDE AND METHODS OF PRODUCTION THEREOF - The present disclosure describes compositions providing for controlled release of nitric oxide (NO) and methods for production of these compositions. In some embodiments, the compositions may include a biodegradable polymer and a nitric oxide-releasing material at least partially encapsulated by the biodegradable polymer. Nitric oxide-releasing materials may include, for example, diazeniumdiolates and nitric oxide contained within a zeolite, metal-organic framework or other porous material. In general, the compositions are spun into a porous fiber, which may be further annealed by heating in order to densify the fiber. Annealing may prolong the NO release profile. Medical devices containing the compositions described herein are also contemplated by the present disclosure. Medical devices include, for example, textiles, bandages and articles of clothing. | 2010-11-11 |
20100285101 | COMPOSITE NONWOVEN FIBROUS WEBS AND METHODS OF MAKING AND USING THE SAME - The disclosure relates to composite nonwoven fibrous webs including a population of sub-micrometer fibers having a median diameter less than one micrometer (μm), and a population of microfibers having a median diameter of at least 1 μm. At least, one of the fiber populations is oriented, and each composite nonwoven fibrous web has a thickness and exhibits a Solidity of less than 10%. The disclosure also relates to methods of making composite nonwoven fibrous webs, and articles including composite nonwoven fibrous webs made according to the methods. In exemplary applications, the articles may be used as gas filtration articles, liquid filtration articles, sound absorption articles, surface cleaning articles, cellular growth support articles, drug delivery articles, personal hygiene articles, or wound dressing articles. | 2010-11-11 |
20100285102 | COLLOIDAL COLLAGEN BURN WOUND DRESSING PRODUCED FROM JELLYFISH - The present invention relates to methods of forming wound dressings from jellyfish collagen. A jellyfish tissue is provided, after which an acid is added to produce a collagen-salt solution. The solution is mixed to form a viscous colloidal gel, and a film or a film/fabric composite is created from the gel. | 2010-11-11 |
20100285103 | MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF - The present invention discloses an anti-tumor conjugate and pharmaceutical composition or kits comprising the conjugate, as well as a method of producing the anti-tumor conjugate. The anti-tumor conjugate of the present invention is metabolically stable in vivo, and is ultimately available for the treatment of tumors and production of anti-tumor medicaments. | 2010-11-11 |
20100285104 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF OXYGEN - H-NOX proteins are mutated to exhibit improved or optimal kinetic and thermodynamic properties for blood gas O | 2010-11-11 |
20100285105 | OIL PRODUCING MICROBES ADN METHOD OF MODIFICATION THEREOF - Disclosed are compositions and methods related to a eukaryote of the order Thraustochytriales and family Thraustochytriaceae which when cultured produce quantities of unsaturated fatty acids, such as omega 3 (n-3) and/or omega 6 (n-6) oils, such as DHA, EPA and DPA, capable of being purified and used as all such compositions are used and more, because of their means of production. | 2010-11-11 |
20100285106 | MULTICOMPONENT VACCINE - The present invention relates, in general, to human immunodeficiency virus (HIV) and, in particular, to a multicomponent vaccine and method of using same to protect against HTV-I infection. | 2010-11-11 |
20100285107 | SHORT NUCLEIC ACID MOLECULE-MEDIATED MODULATION OF AURORA B KINASE EXPRESSION AND COMBINATIONS FOR USE IN ANTICANCER THERAPY - This invention relates to the use of short nucleic acid molecules that modulate Aurora-B kinase (AurkB) expression. The invention includes compounds, compositions and methods useful for the modulation of expression and activity of genes involved in the AurkB pathway. In one embodiment, the present invention provides short nucleic acid molecules, such as siRNA, which can be used in treating, preventing, or inhibiting cancer, and any other proliferative disease, trait or condition, which respond to a reduction in AurkB expression in a cell or tissue. Such short nucleic acid molecules can be used alone or in combination with other treatments or therapies, including short nucleic acid molecules that modulate expression of EGFR. | 2010-11-11 |
20100285108 | Method for therapeutic use - The present invention is related to methods for the therapeutic use in the treatment of diseases and disorders where T-helper independent antibody responses are beneficial. In particular, the present invention relates to a method wherein these diseases and disorders above are treated in immunocompromised or autoimmune diseased animals or humans. Even more particular the present invention relates to the treatment of Alzheimer's disease in immunocompromised or autoimmune diseased animals or humans or where inflammatory reactions need to be specifically avoided. | 2010-11-11 |
20100285109 | TRUNCATED SECRETORY ASPARTYL PROTEINASE 2 - The present invention relates to a truncated form of the secretory aspartyl proteinase 2 (Sap2), as well as to nucleic acid molecules encoding same. This truncated Sap2 polypeptide (tSap2) is surprisingly stable and devoid of enzymatic activity but retains full immunogenicity upon intravaginal administration and confers full protection against intravaginal challenge by the | 2010-11-11 |
20100285110 | COMPOSITION COMPRISING MUCILAGINOUS POLYSACCHARIDES DERIVED FROM ALOE BARBADENSIS COMBINED WITH LIPOSOMES, METHOD FOR OBTAINING SAME AND USE THEREOF AS A SUN PROTECTOR, AN ANTI-ACNE AGENT, AN EPIDERMAL REGENERATOR AND A MOISTURISER - Provided is a composition including mucilaginous polysaccharides of | 2010-11-11 |
20100285111 | SELF-ASSEMBLING MICELLE-LIKE NANOPARTICLES FOR SYSTEMIC GENE DELIVERY - Nanoparticles containing nucleic acid and suitable for use as in vivo delivery agents for nucleic acids are provided. The nanoparticles use a covalent conjugate of a polycation such as polyethylenimine and phospholipids. The final DNA-containing nanoparticle has a vesicular structure with a polyplex core surrounded by a mixed lipid/PEG-lipid monolayer envelope and offers simple preparation, high loading capacity, and in vivo stability. The nanoparticles have good in vivo stability and a prolonged blood circulation time and can effectively deliver a gene to a biological target such as a tumor. | 2010-11-11 |
20100285112 | METHODS OF DELIVERING OLIGONUCLEOTIDES TO IMMUNE CELLS - The invention relates to the field of delivery of nucleic acid-based agents to immune cells. | 2010-11-11 |
20100285113 | ENHANCED STABILITY OF INVERSE THERMAL GELLING COMPOSITE HYDROGELS - The present invention relates to a composite hydrogel comprising a blend of an aqueous solution of an anionic polysaccharide or a derivative thereof, such as hyaluronan (also commonly referred to as hyaluronic acid) or a derivative thereof and an aqueous solution of methylcellulose or another water soluble cellulose derivative thereof, having dispersed polymeric particles, such as polymeric hydrophobic particles therein selected from micro particles and nanoparticles, and wherein the stability of the hydrogel is enhanced relative to the stability of the hydrogel alone. The polymeric particles may contain at least one therapeutic agent, in which case each therapeutic agent exhibits a linear sustained release rate that can be tuned or altered by selecting the appropriate polymer formulation of the micro particles and/or nanoparticles. The composite may be injectable, and in the absence of a therapeutic agent may be used as a bulking agent for reconstructive and cosmetic surgery or may act as a platform for subsequent delivery of therapeutic agents. | 2010-11-11 |
20100285114 | PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN - The invention relates to pharmaceutical compositions of rhein or diacerein, or salts or esters or prodrugs thereof which are bioequivalent to a 50 mg diacerein formulation marketed under the trade name Art 50®. The compositions exhibit no variability in fed and fasted state conditions. The compositions also result in significant reduction in side effects such as, soft stools as compared to Art 50®. The invention also relates to the methods for preparing such compositions. | 2010-11-11 |
20100285115 | Novel Antiretroviral Combination - The invention relates to pharmaceutical compositions containing a combination of atazanavir and ritonavir, to methods of making them, and their use in medicine. | 2010-11-11 |
20100285116 | PHYSICALLY/MOLECULARLY DISTRIBUTED AND/OR CHEMICALLY BOUND MEDICAMENTS IN EMPTY, HARD CAPSULE SHELLS - The present invention incorporates medicaments in the empty hard capsule shells (body and cap). The medicament is either physically/molecularly distributed and/or chemically bound to the polymer matrix of the capsule shell composition. Other medicaments in the form of drug-loaded matrices (powders, granules, beads, pellets, mini-tablets, and mini-capsules) can be filled in the drug-loaded empty, hard capsule shells. The same capsule dosage form contains medicaments in the core matrix and in the shell. | 2010-11-11 |
20100285117 | COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SENSITISERS - The present invention relates to combinations of triazine derivatives and of insulin sensitisers. | 2010-11-11 |
20100285118 | ENCAPSULATED OMEGA-3 FATTY ACIDS AND/OR OMEGA-6 FATTY ACIDS AND/OR ESTERS THEREOF WITH A COATING - Encapsulated omega-3 fatty acids and/or omega-6 fatty acids and/or esters thereof with a coating comprising isoflavones, as well as a process to make such by coating encapsulated omega-3 fatty acids and/or omega-6 fatty acids and/or esters thereof with a coating comprising isoflavones. | 2010-11-11 |
20100285119 | Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same - Disclosed herein is an extended release pharmaceutical composition comprising at least two populations of extended release minitablets having a core comprising carbamazepine or its pharmaceutical salts, solvates, hydrates, an extended release polymer(s), wherein the extended release polymer of each population of minitablets is unalike. The process for manufacturing said composition is also disclosed. | 2010-11-11 |
20100285120 | CONTROLLED RELEASE PREPARATION - A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient. | 2010-11-11 |
20100285121 | Capsule Formulation - The present invention provides the following capsule preparation, which is superior in dissolution property and the like of a pharmaceutically active ingredient and contains liquid and solid pharmaceutically active ingredients: a seamless capsule containing liquid and solid pharmaceutically active ingredients, wherein the liquid pharmaceutically active ingredient is encapsulated in the form of a liquid pharmaceutical composition, and the solid pharmaceutically active ingredient is dispersed in a capsule shell layer. | 2010-11-11 |
20100285122 | TABLETS FOR COMBINATION THERAPY - The invention provides solid dose forms (e.g. tablets) comprising a compound of Formula I, a compound of Formula II, a compound of Formula III and a salt of Formula IV. | 2010-11-11 |
20100285123 | Controlled Release Dosage Formulation of Duloxetine - The preset invention provides a controlled release dosage form of duloxetine comprising a homogenous core comprised of duloxetine or its pharmaceutically acceptable salts, pharmaceutically acceptable polymeric carrier, solubility enhancer, a hydrophobic component, a hydrodynamic diffusion enhancer, a viscolyzing agent and pharmaceutically acceptable excipients; a entering coat on said core and a barrier layer between said core and the enteric coat. | 2010-11-11 |
20100285124 | TETRAHYDROCYCLOPENTA[C]ACRIDINE DERIVATIVES AS KINASE INHIBITORS AND BIOLOGICAL - The invention relates to kinase inhibitors of the formula (I) in which —R | 2010-11-11 |
20100285125 | DELIVERY SYSTEM FOR POORLY SOLUBLE DRUGS - The present invention relates to an oral drug delivery system for poorly soluble drugs, which can provide sustained near zero order release of poorly water soluble drugs from erodible matrix systems. Erodible matrix core is prepared using at least one active and erosion modulators in a matrix of low molecular weight and high molecular weight hydrophilic polymers in combination with a pH sensitive polymer which enable uniform hydration, controlled erosion and pH independent drug release through out GIT. The core optionally contains solubilizers. The core is optionally coated using combination of low molecular weight water soluble and water insoluble polymers, plasticizer and fillers, which provides for drug release, following a lag time, which also helps to reduce food effects in the stomach. | 2010-11-11 |
20100285126 | PHARMACEUTICAL COMPOSITIONS OF FENOFIBRATE - The invention relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more pharmaceutically acceptable vehicles. The invention also relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more cyclodextrin derivatives. The invention also relates to processes for the preparation of such compositions. | 2010-11-11 |
20100285127 | TASTE MASKED PHARMACEUTICAL COMPOSITIONS OF S-ALKYLISOTHIOURONIUM DERIVATIVES - The present invention relates to taste masked compositions of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, in the form of a coated oral tablet having a desirable dissolution profile. | 2010-11-11 |
20100285128 | SPACE FILLED DRUG RELEASE STRUCTURE AND METHOD OF MANUFACTURING THE SAME - A space filled drug release structure and a method of manufacturing the same are disclosed. The structure is composed of a highly water-absorbing polymeric matrix and drug particles dispersed in the matrix. The matrix has pores and passages interconnecting the pores together. Because some water is present in the matrix, gastric acid can easily penetrate into the matrix to reach each drug particle. The surface of each drug particle is therefore possible to contact with the gastric acid. The drug releasing rate is therefore fast. Such structure is helpful for those drugs with low dissolution ability in the gastric acid. | 2010-11-11 |
20100285129 | NOVEL AGENT FOR SALTING OUT ACTIVE PRINCIPLES IN DRESSINGS CONTAINING AT LEAST ONE OF FATTY SUBSTANCE - The present invention relates to the use, as an agent for salting out an active substance in a composition for a dressing, of a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulphonic acid and the 2-hydroxyethyl ester of propenoic acid. It also relates to dressings of the type comprising at least one fatty substance and/or an elastomeric matrix and at least one active substance, which incorporate the aforementioned copolymer. | 2010-11-11 |
20100285130 | COATING OF COMPLEXED ACTIVES IN FILM FORMULATIONS - The present invention relates to products and methods of making products having a dual taste masked active component. In particular, the present invention relates to film dosage forms including at least one dual taste masked active, where the dual taste masked active includes a coated complexed active composition. | 2010-11-11 |
20100285131 | FGF21 MUTANTS AND USES THEREOF - The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions. | 2010-11-11 |
20100285132 | IMMUNOTHERAPY COMPOSITIONS, METHOD OF MAKING AND METHOD OF USE THEREOF - The present invention directs to compositions and methods for modulating immune system. One aspect of the present invention relates to a composition comprising FADD-dependent signaling pathway modulators. Another aspect of the 5 present invention relates to biodegradable microparticles, such as a chitosan microparticic, or PLGA/PEI microparticle, designed to deliver nucleic acids and/or proteins, such as FADD-dependent signaling pathway modulators, to boost different pathways of an immune response. Another aspect of the present invention relates to the method of making biodegradable microparticles. The further aspect of the present invention relates to the use of the chitosan and other polycationic microparticles to deliver FADD-dependent signaling pathway modulators to modulate immune system for the prevention and/or treatment infectious diseases and cancers. | 2010-11-11 |
20100285133 | TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING GRANISETRON - Disclosed herein is a transdermal system in a matrix form capable of enhancing granisetron carrying efficiency and improving transdermal absorption while inhibiting recrystallization, which comprises: at least one transdermal enhancer selected from a group consisting of polyglyceryl-3 oleate, polyethyleneglycol-20 almond glyceride, polyethyleneglycol-12 palm kernel glyceride, isopropyl myristate and oleyl alcohol; and an acrylate polymer. | 2010-11-11 |
20100285134 | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES - An intra-articular pharmaceutical composition is used for the treatment and/or the prevention of acute or chronic osteoarticular diseases and acute or chronic osteoarticular symptoms especially osteoarthritis. The composition includes a possibly adequate pharmaceutical carrier or diluent, a glycosaminoglycan, a compound activating the alpha 2 adrenergic receptor, an anti-inflammatory agent and stem cells. | 2010-11-11 |
20100285135 | Nanoparticles For Use In Immunogenic Compositions - Disclosed herein are sterile-filtered lyophilized nanoparticle compositions which contain at least one biodegradable polymer, at least one surfactant, at least one cryoprotective agent and at least one antigen. Also disclosed are methods of making and using such compositions and kits supplying such compositions. | 2010-11-11 |
20100285136 | SYSTEM COMPRISING BACTERIOPHAGES AND PARTICLES THAT CONTAIN ACTIVE SUBSTANCES - The present invention concerns a system, comprising bacteriophages and particles comprising active agents, in which a first additional peptide is fused to proteins of the bacteriophage, the first additional peptide adheres to the surface of the particle and furthermore a second additional peptide is fused to proteins of the bacteriophage. The second additional peptide can adhere on substrate surfaces. The present invention furthermore concerns the use of the system for delayed release of active agents and also a method for production of the system. The present invention furthermore concerns a method for the selection of phage species from a combinatorial phage population. | 2010-11-11 |
20100285137 | ANTIBIOTIC/BONE MORPHOGENIC PROTEIN FORMULATION AND METHOD OF TREATMENT - A formulation comprised of particles which may be in groups and are comprised of a biocompatible polymer and an antimicrobial drug for controlled release of the drug is disclosed. The particles may be in an aqueous solution comprising thrombin and be dispersed in a gel. The formulation is administered to an area such as an open wound having an orthopedic implant therein and provides a therapeutically effective level of drug to the patient over therapeutically effective period of time. | 2010-11-11 |
20100285138 | COMPOSITIONS COMPRISING NANOPARTICLES AND APOPTOTIC AGENTS AND METHODS OF USE - Compositions comprising nanoparticles, such as silver or gold nanoparticles or carbon nanotubes (CNTs), and apoptotic agents are described. The nanoparticles can significantly enhance the cancer chemotherapeutic effects of the apoptotic agents. In particular, a highly increased anti-tumor activity has been demonstrated for the combination of etoposide and CNTs against HeLa cells compared to the administration of either etoposide alone or nanoparticles alone. Data provided by flow cytometry, Caspase 3 and other methods, suggest a strong interaction between the nanoparticles and the cellular structure, which can result in the improved effectiveness of chemotherapeutic agents. These findings provide potential new cancer therapies by carefully selecting the right combination of cytostatic drugs and nanostructural materials which synergistically provide significantly greater curative rates. | 2010-11-11 |
20100285139 | PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR SYMPTOMATIC TREATMENT OF CYSTIC FIBROSIS - A pharmaceutical composition for prophylaxis and/or treatment of infections and/or infectious diseases occurring in cystic fibrosis includes at least one antidepressant; at least one dispersant; and at least one pharmaceutically tolerable carrier material. | 2010-11-11 |
20100285140 | ANTIMICROBIAL AGENT FOR GRAM-POSITIVE BACTERIA - A novel antibacterial agent for Gram-positive bacteria which disregards the drug-resistant mechanisms of bacteria is disclosed. The antibacterial agent contains as an effective ingredient particles having a particle diameter of not more than 5 μm, which particles are adhesive to cell wall of Gram-positive bacteria and not adhesive to mammalian cell membrane and substantially do not contain an active antibacterial ingredient effective against Gram-positive bacteria. By the antibacterial agent according to the present invention, the growth of the multidrug-resistant Gram-positive bacteria such as MRSA and VRE can be inhibited, as well as the occurrence of novel multidrug-resistant bacteria, which is a big problem in use of antibiotics, can be avoided. | 2010-11-11 |
20100285141 | COMPOSITIONS AND METHODS FOR ENHANCING THE ACTIVITY OF PODOPHYLLOTOXIN - A method of increasing an activity of a podophyllotoxin or a derivative thereof is disclosed. The method comprises contacting the podophyllotoxin or the derivative with a liquid composition having a liquid and nanostructures, each of the nanostructures comprising a core material of the nanometric size surrounded by an envelope of ordered fluid molecules, the core material and the envelope of ordered fluid molecules being in a steady physical state, thereby increasing the activity of the podophyllotoxin or the derivative. Pharmaceutical compositions comprising same and uses thereof are also disclosed. | 2010-11-11 |
20100285142 | Method Of Making Particles For Use In A Pharmaceutical Composition - A method for making composite excipient particles for use in a pharmaceutical composition comprises a milling step in which particles of an excipient material are milled in the presence of an additive material. The product particles are of small size and the milling requires relatively low input of time and energy. The composite particles are suitable for use in inhalable pharmaceutical compositions. | 2010-11-11 |
20100285143 | ORALLY ADMINISTERABLE SOLID PHARMACEUTICAL COMPOSITION AND A PROCESS THEREOF - The invention relates to improvised pharmaceutical compositions permitting ingestion via oral delivery of proteins/peptides or their conjugates, and/or cation-insulin conjugate complexes demonstrating desirable pharmacokinetic profiles and potency in efficacy models of diabetes in dogs and humans. A preferred formulation comprises 0.01%-20% w/w of insulin, insulin compound conjugates and/or cation insulin conjugates, 10%-60% w/w of one or more fatty acid components selected from saturated or unsaturated C4-C12 fatty acids and/or salts of such fatty acids and additionally contains optimal amounts of other pharmaceutically suitable polymer excipients which permit improved solubility, dissolution rate and effective bioavailability of poorly water soluble compositions and consistent in-vivo release profiles upon scalability during manufacture. A further aspect of the invention features the process of preparing the aforesaid formulations. | 2010-11-11 |
20100285144 | POLYMER-EPOTHILONE CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE - Described herein are polymer-agent conjugates and particles, which can be used, for example, in the treatment of cancer or neurological deficits. Also described herein are mixtures, compositions and dosage forms containing the particles, methods of using the particles (e.g., to treat a disorder), kits including the polymer-agent conjugates and particles, methods of making the polymer-agent conjugates and particles, methods of storing the particles and methods of analyzing the particles. | 2010-11-11 |
20100285145 | GPR 119 MODULATORS - Compounds of Formula (I) that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein. | 2010-11-11 |
20100285146 | PEPTIDES AND METHODS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS - A method is disclosed for treating systemic lupus erythematosus in a mammalian subject, comprising administering to said subject an effective dose of at least one laminin peptide, or an analog or a derivative thereof. In one exemplary embodiment, the laminin peptide is selected from the group consisting of R38 (SEQ. ID. NO. 1), and claimed R38 analogs and derivatives thereof including 5200 (SEQ. ID. NO. 10), 5104 (SEQ. ID. NO. 15), 5105 (SEQ. ID. NO. 16), 5106 (SEQ. ID. NO. 17), 5107 (SEQ. ID. NO. 18), 5108 (SEQ. ID. NO. 19), 5109 (SEQ. ID. NO. 20), 5110 (SEQ. ID. NO. 21). The laminin peptides of the present invention may be prepared by known chemical synthetic methods or by biotechnological methods. The invention also provides assays useful for the diagnosis of and following pathological activity course of systemic lupus erythematosus in patients suffering therefrom. In addition, the subject invention concerns a method of treating systemic lupus erythematosus in a subject comprising the extracorporeal removal of lupus antibodies from the subject's plasma and returning the plasma to the subject. In an additional aspect, the invention provides method of reducing anti-R38 antibody levels in a patient's plasma. | 2010-11-11 |
20100285147 | CRUDE DRUG EXTRACT-BLENDED LIQUID MEDICINE - Provided an acidic liquid preparation containing a herb and/or animal-origin extract at high concentration to suppress time-dependent occurrence of precipitation and/or opacity. | 2010-11-11 |
20100285148 | ORAL CARE METHOD AND KIT - A method of moisturizing while decolonizing mammalian tissue, the method comprising applying a multi-valent cationic antiseptic composition to the tissue, and applying a moisturizer composition to at least a portion of the same tissue; wherein the mammalian tissue is oral tissue of a subject; wherein the multi-valent cationic antiseptic is other than a metal ion; and wherein the applied compositions essentially exclude any component which causes a precipitate when combined with a multi-valent cationic antiseptic contained in the multi-valent cationic antiseptic composition when tested according to Test Method F, and/or wherein the moisturizer composition is such that a log reduction in the number of viable bacterial cells of at least 2 is provided when 10 | 2010-11-11 |
20100285149 | NOVEL TETRAHYDROPYRIDOTHIOPHENES - Compounds of a certain formula I, in which Ra and Rb have the meanings indicated in the description, are novel effective compounds with anti-proliferative and apoptosis inducing activity. | 2010-11-11 |
20100285150 | DENTAL STERILIZING WATER, METHOD FOR PRODUCING THE WATER, AND DEVICE FOR PRODUCING THE WATER - This aims to produce dental sterilizing water having not only a sterilizing action but also an action to break a bio-film. Provided is a sterilizing water producing device ( | 2010-11-11 |
20100285151 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH INFECTION AND/OR INFLAMMATION - The present invention provides methods and compositions for treating and preventing conditions characterized by infection and/or inflammation, especially of the eyes, ears, nose, and/or throat. The methods of the invention involve administering hypohalous acid to the patient, such as in the form of a composition described herein. | 2010-11-11 |
20100285152 | COMPOSITION FOR IMPROVING LIVER METABOLISM AND DIAGNOSTIC METHOD - There is a need to develop a treatment for metabolic syndrome, which is directed to maintaining healthy liver metabolism and not indirectly through weight loss. The present invention provides a composition comprising whey protein for supporting and improving liver metabolism, especially in connection with fatty liver. The composition can further comprise Ca and health improving components such as probiotics and prebiotics. The composition can be in the form of food, health food, food supplement or drugs. Furthermore, due to the complexity of choice of a valid biomarker and sample matrix, there is a special need to find out specific biomarkers for fatty liver and metabolic syndrome. This invention also relates to a diagnostic method for determining fatty liver on the basis of metabolomic profiling. Statistical modelling methods are used on the metabolomic profiles to identify the biomarkers. | 2010-11-11 |
20100285153 | Lipolysis Stimulator - To provide a lipolysis agent, a slimming agent, and a cellulite-ameliorating agent, which stimulate decomposition of fat accumulated in the adipose tissue, to thereby exhibit body-slimming effect and which is effective for inhibition or prevention of obesity and amelioration of prone to obesity. The lipolysis stimulator of the invention contains, as effective ingredients, a plant Huang Hua Cai or an extract thereof, and a xanthine derivative. | 2010-11-11 |
20100285154 | USE OF LIGNAN COMPOUNDS FOR TREATING OR PREVENTING INFLAMMATORY DISEASE - The present invention relates to the use of lignan compounds for treating or preventing an inflammatory disease. More particularly, it relates to a method for preventing or treating an inflammatory disease, comprising administering to a subject in need thereof an effective amount of macelignan represented by Chemical Formula I or a pharmaceutically acceptable salt thereof. The lignan compound has the effect of inhibiting inflammatory reactions by inhibiting the production or expression of inflammation mediators NO, iNOS, PGE | 2010-11-11 |
20100285155 | CLEANSER COMPOSITION AND METHODS FOR USING THE SAME - The present invention is directed to anti-microbial cleanser compositions comprising linalool, hinokitiol and dipropylene glycol. The present invention further provides methods for using these compositions to maintain eyelid hygiene, to treat an ocular disorder or to clean a skin surface. The cleanser compositions of the present invention can be in the form of a foam, gel or liquid. | 2010-11-11 |
20100285156 | COMPOSITION FOR PREVENTING AND TREATING METABOLIC DISEASES COMPRISING THE EXTRACT OF LYSIMACHIAE FOENUM-GRAECI HERBA - Disclosed are raw material, functional foods, and herb medicines for preventing and treating metabolic diseases, which comprise a Lysimachiae Foenum-Graeci Herba extract as an effective ingredient. The Lysimachiae Foenum-Graeci Herba extract have an activity of reducing blood glucose levels, triglycerides and cholesterol levels, AST and ALT levels, and fat in the liver, and thus can be effectively used as a hepatic protector and a remedy for preventing and treating various metabolic diseases including diabetes, high blood pressure, fatty liver, cardiovascular diseases, and hyperlipidemia. | 2010-11-11 |
20100285157 | GRANULES, TABLETS AND METHOD OF PRODUCING THE SAME - When a light and porous inorganic substance is employed in a large amount as a excipient, it is impossible in the subsequent tabletting step using a tabletting machine to supply a desired amount of the resultant powder into a mortar having a definite diameter. As a result, extremely light tablets are produced. A method of producing the tablet is characterized by including dissolving or dispersing an oily substance, a liquid substance derived from a natural product or a low-melting substance in an organic solvent, allowing a porous calcium silicate powder to adsorb and hold the solution, adding a starch and/or a saccharide thereto, granulating the obtained mixture to give granules having an appropriate loose bulk density, and then compression molding those granules to give tablets. | 2010-11-11 |
20100285158 | EFFERVESCENT COMPOSITION INCLUDING CRANBERRY EXTRACT - Disclosed is an effervescent composition that includes an effervescent agent and cranberry extract, preferably in an amount sufficient to decrease the measurable amount of bacteria present in the urine of an individual having a urinary tract infection. | 2010-11-11 |
20100285159 | COMBINATION OF UNSAPONIFIABLE LIPIDS COMBINED WITH POLYPHENOLS AND/OR CATECHINS FOR THE PROTECTION, TREATMENT AND REPAIR OF CARTILAGE IN JOINTS OF HUMANS AND ANIMALS - The present invention relates to a composition and a kit for the protection, treatment and repair of cartilage in humans and animal joints. The composition or kit contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. Preferably, the composition or kit contains avocado:soybean unsaponifiables (ASU) and green tea. | 2010-11-11 |
20100285160 | ANTI-INFLUENZA VIRAL COMPOSITION CONTAINING BARK OR STEM EXTRACT OF ALNUS JAPONICA - The present invention relates to an antiviral composition comprising an | 2010-11-11 |
20100285161 | HERBAL COMPOSITION FOR MAINTAINING/CARING THE SKIN AROUND THE EYE, METHODS OF PREPARING THE SAME AND USES THEREOF - Disclosed is a novel herbal composition for maintaining/caring the skin around the eye, the composition comprising extracts of | 2010-11-11 |
20100285162 | HERBAL COMPOSITION FOR MAINTAINING/CARING THE SKIN AROUND THE EYE, METHODS OF PREPARING THE SAME AND USES THEREOF - Disclosed is a novel herbal composition for maintaining/caring the skin around the eye, the composition comprising extracts of | 2010-11-11 |
20100285163 | Composition for Treating or Preventing Hot Flashes and use Thereof - The present invention provides compositions and methods of their use for treating or preventing climacteric symptoms such as hot flashes. A composition of the invention preferably comprises Chaihu, Yujin, Mudanpi, Zicao, Baiwei, Baishao and Wuweizi or extracts thereof, and is preferably administered as a single composition. | 2010-11-11 |
20100285164 | Orally Disintegrating Excipient - The present invention is directed to coprocessed excipient particles comprising a cellulosic material such as microcrystalline cellulose in intimate association with silicon dioxide, a disintegrant and a polyol, sugar or a polyol/sugar blend. The excipient particles display good processing and are useful in prepared compressed solid dosage forms that exhibit rapid disintegration (less than about 60 seconds) when placed on the tongue or when tested according to USP disintegration testing, while still providing acceptable mouth feel. | 2010-11-11 |
20100285165 | SCREW EXTRUDER FOR CONTINUOUS EXTRUSION OF MATERIALS WITH HIGH VISCOSITY - Screw extruder for the continuous extrusion of materials with high viscosity, in particular metals such as aluminium and its alloys. The extruder includes an Archimedes screw ( | 2010-11-11 |
20100285166 | ROTARY PRESS - A rotary press, with a rotor rotatingly drivable around a vertical axis, which features a die plate having die bores on a partial circle and upper and lower punches guided in guiding devices, radial cams for the upper and lower punches, at least two compression stations spaced apart in the circumferential direction and with an upper and a lower compression roller, a first filling device in the circumferential direction of a first compression station and a second filling device located behind the first compression station in the circumferential direction, wherein the rotor features an annular surface in a radial distance to the partial circle for the die bores and being concentric to the rotational axis of the rotor, wherein first deflecting means are provided between the second compression station and the first filling device that direct the ejected pressed articles towards the annular surface, second deflecting means are provided that direct the pressed articles from the annular surface towards off from the rotor, and third deflecting means behind the first compression station in the circumferential direction which direct the pressed articles ejected from the die bores towards off from the rotor, characterised in that the annular surface is disposed radially inside the partial circle and limited towards the partial circle by an annular stationary lock-out between the first and the second deflecting means. | 2010-11-11 |
20100285167 | TEMPLATES FOR USE IN IMPRINT LITHOGRAPHY AND RELATED INTERMEDIATE TEMPLATE STRUCTURES - A method of forming a template for use in imprint lithography. The method comprises providing an ultraviolet (“UV”) wavelength radiation transparent layer and forming a pattern in the UV transparent layer by photolithography. The pattern may be formed by anisotropically etching the UV transparent layer and may have feature dimensions of less than approximately 100 nm, such as dimensions of less than approximately 45 nm. An additional embodiment of the method comprises providing a UV opaque layer comprising a first pattern therein, forming a first UV transparent layer in contact with the first contact pattern of the UV opaque layer, forming a second UV transparent layer in contact with the first UV transparent layer, and removing the UV opaque layer to form the template. An intermediate template structure for use in imprint lithography is also disclosed. In other embodiments, a template that is opaque to UV wavelength radiation and a method of forming the same are disclosed. | 2010-11-11 |
20100285168 | ANTISTATIC SILICONE RUBBER MOLD-MAKING MATERIAL - An antistatic silicone rubber mold-making material is provided. This mold-making material comprises a silicone rubber composition which is curable by an addition reaction, and which contains an ionically conductive antistatic agent. The article produced by curing this antistatic silicone rubber mold-making material retains the insulator performance and the article exhibits excellent antistatic properties. Also, the article can be colored as desired. | 2010-11-11 |
20100285169 | APPARATUS FOR BLOW MOULDING PLASTIC PREFORMS HAVING A REDUCED DEAD VOLUME - A blow moulding apparatus for expanding plastic preforms into plastic containers may include a blow piston extending in a longitudinal direction and a blow nozzle extending from the blow piston in the longitudinal direction. The blow nozzle may be configured to apply a gaseous medium to a preform for the expansion thereof. A connection device may be structured and arranged to supply the gaseous medium to the blow moulding apparatus via at least two connection lines, and a control block may be arranged between the connection device and the blow piston. The control block may be configured to control the supply of the gaseous medium during the expansion process using at least partially varying pressure levels and may have a plurality of channels for guiding the gaseous medium. The plurality of channels may be separated from each other at least in sections and may be distributed in a circumferential direction of the control block. At least two valves may be on an outer circumference of the control block. The valves may be distributed in a circumferential direction around the control block, and may be controlled independent of one another for controlling the supply of the gaseous medium to the blow nozzle. A distribution member may be configured to guide the gaseous medium into said channels. The distribution member may be arranged between the connection device and the control block if viewed in the flow direction of the gaseous medium. The channels may extend within the control block at least in sections substantially parallel to the longitudinal direction of the blow piston. | 2010-11-11 |
20100285170 | COUPLING APPARATUS AND METHOD - An injection molding system comprising an actuator, a mounting plate, a mold and a manifold mounted between the mounting plate and the mold, the mounting plate being removably coupled to the mold, the actuator comprising an actuating member reciprocally drivable along an axial path of travel and a housing removably coupled to the mounting plate; a valve pin coupled to the shaft of the actuator for movement of the valve pin together with movement of the actuating member, the valve pin comprising a pin stem and a pin connector; the actuator having an actuator coupling adapted to reversibly couple to and decouple from the pin connector in a radial direction relative to the axial path of travel, the pin stem extending from the actuator into the manifold when the housing of the actuator is coupled to the mounting plate and the pin connector is received within the actuator coupling; the actuator housing being mounted on or within the mounting plate for radial movement upon decoupling of the actuator housing from the mounting plate such that the pin connector is decouplable from the actuator coupling upon said radial movement while the actuator housing is disposed on or within the mounting plate, the actuator being removable from on or within the mounting plate leaving the valve stem behind extending into the manifold. | 2010-11-11 |
20100285171 | POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME - The present invention relates to isolated polypeptides and isolated nucleic acid sequences encoding the polypeptides, as well as methods for producing and using the polypeptides in animal feed. An example of a polypeptide of the invention is the so-called L12 protein from | 2010-11-11 |
20100285172 | Metered Conveyor Feed System For Gum Components - Methods and apparatuses are provided for conveying gum components and for making chewing gum compositions, by conveying a substantially horizontally stratified flow of two or more gum components along a conveying path. Once the horizontally stratified flow of gum components is established, the flow of gum components can be supplied to a gum mixing machine in a substantially constant cross-sectional ratio of the gum components, even where it is necessary to adjust the rate of flow of gum components along the conveying path, or to periodically start and stop the flow of components during the gum making process. | 2010-11-11 |
20100285173 | GLUCOSE-INDUCED INACTIVATION/DEGRADATION-RESISTANT TRANSPORTER GENE AND USE THEREOF - The present invention relates to a glucose-induced inactivation/degradation resistant transporter gene and use thereof, and more particularly to a brewery yeast having excellent assimilability of oligosaccharides (maltose, maltotriose, etc.), an alcoholic beverage produced using the yeast, and so on. In particular, the present invention relates to a glucose-induced inactivation/degradation resistant transporter such as Mal21p, etc., a gene encoding the same, a method of producing an alcoholic beverage using the same; and so on. | 2010-11-11 |
20100285174 | Focaccia bread and recipe - A pre-mixed package for making focaccia bread. The package includes a polymeric package material having an inner region and an outer region, e.g., plastic bag, sealed plastic bag, coated bag. The package includes at least a flour material having a volume and weight provided within the inner region, and a yeast material mixed with the flour material. The polymeric package material is substantially sealed from an exterior region for shipping, storage, and distribution before being used. Of course, there can be other variations, modifications, and alternatives. | 2010-11-11 |
20100285175 | Method for Producing a Dairy Product - The present invention relates to a method for producing a dairy product using an enzyme having lactase activity. | 2010-11-11 |
20100285176 | FERMENTATION PRODUCT OF ALOE, METHOD OF MANUFACTURING THE SAME AND FUNCTIONAL FOODS USING THE SAME - There are provided a fermentation product of aloe, a method of manufacturing the same and functional foods using the same. More particularly, the present invention relates to a method of manufacturing a fermentation product of aloe by culturing mushroom mycelia in an aloe natural medium containing many effective ingredients and thus having diverse bioactive effects, and a method of manufacturing functional foods having various pharmacological effects of improving stomach function, enhancing immunity and having effectiveness against cancer by using the fermentation product of aloe. | 2010-11-11 |
20100285177 | METHOD OF PRODUCING GABA-CONTAINING FERMENTED PRODUCT - It is intended to provide a method of efficiently producing a fermented fruit or vegetable product which contains GABA at an elevated concentration without damaging the inherent flavor of the fruit or the vegetable. A method of producing a fermented product containing γ-aminobutyric acid which is characterized by comprising fermenting a plant or its press juice by using | 2010-11-11 |
20100285178 | PRODUCTION OF FOOD PRODUCTS WITH ENHANCED IN MOUTH AND MENTAL REFRESHMENT - The present invention relates to food products, in particular frozen desserts providing and enhanced refreshing sensation upon consumption and to a method for the manufacture thereof. Furthermore, the present invention relates to refreshing consumable compositions which can be used in the manufacture of said frozen desserts. The food products comprise at least one salivating agent and at least one cooling agent in a weight ratio of 1:0.06 to 1:0.2 | 2010-11-11 |
20100285179 | EDIBLE ENERGY COMPOSITION WITH LOW CAFFEINE - An energy composition includes a methylated xanthine, a choline derivative, and at least one flavorant in a sufficient amount to render the energy composition palatable. The energy composition may also include vitamins, amino acids, enzymes, preservatives, and the like. | 2010-11-11 |
20100285180 | DONENESS INDICATOR FOR HEAT-IN PACKAGING AND METHOD OF MAKING SAME - A heat-in package with doneness indicator for heating applications, such as microwave heating of foods or sterilization applications. The doneness indicator comprises indicia printed with thermochromatic ink on the heat-in packaging. The doneness indicator can be sealed from front to back on the heat-in packaging in such a way that the heat transfer to the sealed area is controlled so that the contents contained within the heat-in packaging has adequate time to heat before a color change or other visual transformation is observed in the doneness indicator. Furthermore, the sealed area containing the thermochromatic ink is not in direct contact with the contents within the packaging. The ink changes due to heat conduction through the film. A venting system can further be incorporated to prevent excessive pressure build-up within the packaging. | 2010-11-11 |
20100285181 | UNCONVENTIONAL EDIBLE FOOD PRODUCTS - A food product having an unconventional design, such as that resembling meat from a prehistoric animal, may be made by attaching meat to a large beef rib bone. The beef rib bone may be made to resemble a rib from a prehistoric animal. | 2010-11-11 |
20100285182 | CONTAINER-PACKED BLACK COFFEE BEVERAGE - Disclosed is a container-packed black coffee beverage which has an excellent hypertension ameliorating effect and can be ingested in an ordinary manner. A container-packed black coffee satisfying the following requirements (A) to (C): (A) a chlorogenic acid: 0.01 to 1% by mass; (B) hydroxyhydroquinone: 0.1% by mass or less relative to the mass of the chlorogenic acid; and (C) the chlorogenic acid/a coffee solid content ≧0.025 (by mass). | 2010-11-11 |
20100285183 | Oil Resistant Packaging - Oil resistant package material and packages prepared therefrom have cyclodextrin incorporated in or adjacent to a film layer of the package to reduce the permeation of oil through the package material, and particularly out of the package. The film layer comprises a polymer that coordinates or bonds with a cyclodextrin compound in an amount sufficient to reduce the permeation of oil through the film layer as compared to a like film layer that does not contain cyclodextrin. | 2010-11-11 |
20100285184 | Foodstuff Containing Packaging, The Foodstuff Being Fresh And Natural Kiwi Fruit - Packaging comprising:—at least a foodstuff ( | 2010-11-11 |
20100285185 | Process for gelatinising starch using a biodegradable polymer material bearing aldehyde groups - The invention provides a process wherein starch and/or a starch derivative can be gelatinised more efficiently by means a thermo mechanical treatment, when a carbohydrate polymer is used comprising aldehyde containing monomer units which comprise one or more aldehyde groups that are derived from one or more a primary alcohol groups. With this process a granulate or other semi-finished product can be obtained that can be shaped to produce an article that has excellent dimensional stability in water. The invention further provides a granulate, a shaped starch product, a food product or a blown starch film comprising such a carbohydrate polymer. | 2010-11-11 |
20100285186 | Process for the Manufacture of Sugar and Other Food Products - A process for manufacturing of sugar products having desired levels of specific phytochemicals comprising the steps of: preparing a primary sugar product; analysing said primary sugar product for its phytochemical profile using an analytical method selected from the group consisting of near infrared spectroscopy, electrical conductivity, and combinations thereof; comparing said profile; treating said primary sugar product, if required, to achieve a final sugar product having desired levels of specific phytochemicals. | 2010-11-11 |
20100285187 | APPARATUS AND METHODS FOR CUTTING INDIVIDUAL PIECES FROM A FOOD EXTRUDATE - A cutting mechanism ( | 2010-11-11 |
20100285188 | PROCESS FOR PREPARING SOONG-NEUNG IN ASEPTIC PACKAGE - The present invention relates to the process for preparing Soong-Neung in aseptic package by mixing roasted rice and polished rice and adding water-for-cooking rice which is hot water extracts of the roasted rice to prepare Soong-Neung and sealing Soong-Neung under the aseptic condition and boiling cooling followed by boiling to prepare instant Soong-Neung in aseptic package, the prepared Soong-Neung in aseptic package can be preserved for a long time of more than 6 month at room temperature by the sterilization process, and have maximized perfume peculiar to Soong-Neung as diffusing perfume of roasted rice, and have a peculiar stickiness and thus have no change in perfume of Soong-Neung, and is excellent characteristics in divergency and smooth taste as erupting starch material from rice to water-for-cooking rice, such that Soong-Neung of the present invention is equivalent in quality to that of prepared by conventional home cooking method and can be preserved for a long time. | 2010-11-11 |
20100285189 | Filtering and/or Flocculating Aids for the Purification of Liquid Foods - The present invention relates to new filtering and/or flocculating aids for the purification of liquid foods comprising an adsorbing agent and a spacer, wherein the spacer particles are intrinsically hydrophobic or hydrophobised, and the adsorbing agent particles are intrinsically hydrophobic or hydrophobised and are associated to the spacer particles forming a composite therewith, as well as to a method for their preparation, a process for removing impurities from liquid foods, the use of the improved filtering and/or flocculating aids, a filter cake and precoat used for the purification of liquid foods, as well as a liquid food comprising said filtering and/or flocculating aids. | 2010-11-11 |
20100285190 | PROCESS FOR REMOVING ETHENE FROM BIOLOGICAL USING METAL EXCHANGED TITANIUM ZEOLITES - The instant invention relates to a process for removing ethene from biological sources using metal ion exchanged titanium zeolites. Further aspects of the invention are polymer compositions containing these zeolites, their use as efficient ethene removing additives and the modified titanium zeolites self. | 2010-11-11 |
20100285191 | ABSORBENT FOOD PAD AND METHOD OF USING SAME - The present invention provides a food preservation system that includes an absorbent food pad that has absorbent material to absorb exuded liquids from a food product, and has an oxygen scavenging system to modify the atmosphere in the food package. Also disclosed is a method of using the absorbent food pad to enhance appearance of the food product and extend shelf life. | 2010-11-11 |
20100285192 | METHOD FOR FILTERING A LIQUID - The present invention is directed to a method for filtering a liquid, such as beer, comprising carrying out the filtration of said liquid in the presence of a filter aid, wherein said filter aid essentially comprises porous or non porous polyolefin particles having a specific mass less than 1000 kg/m3 and having an at least partly oxidized outer surface, whereby said outer surface is provided with nodular structures. | 2010-11-11 |
20100285193 | METHOD OF TREATING LIQUID FOOD - The present invention suggests a method for treating a liquid food, which is suitable for efficiently and effectively decreasing the dissolved oxygen concentration in liquid foods having high foaming property and low defoaming property such as skim milk. The dissolved oxygen concentration of the liquid food is decreased by putting the liquid food into a decompression vessel while heating the liquid food to a temperature higher than or equal to the saturation temperature (boiling point) of the liquid food under the decompression atmosphere in the decompression vessel, or putting the liquid food into a decompression vessel while depressurizing the decompression vessel to a pressure lower than or equal to the saturation vapor pressure of the liquid food at the temperature of the liquid food. | 2010-11-11 |
20100285194 | TOP AND TAIL SYSTEM FOR LEAFY VEGETABLES - A leafy vegetable having a core end and a leafy end is processed after being harvested. The harvested leafy vegetable is transported to a trim area on a conveyor. A first cutting implement located in the trim area trims a portion of the core end. A second cutting implement located in the trim area trims a portion of the leafy end. The first and second cutting implements are spaced a set distance apart, which defines an amount of the leafy vegetable remaining after the portions of the core and leafy ends are trimmed. As the portions of the core and leafy ends of the leafy vegetable are being trimmed by the first and second cutting implements, a set of one or more nozzles located in the trim area sprays a rinsing liquid on cut sites on the leafy vegetable to rinse off natural juices exuding from the cut sites. | 2010-11-11 |